The overarching goal of this proposal is to investigate the relationship between the structure of stereoisomeric DNA Interstrand Crosslinks (ICLs) formed by Mitomycin C and Decarbamoylmitomycin C and the molecular mechanisms of these drugs. Mitomycin C (MC) is an anticancer drug currently used to treat stomach, anal and lung cancers. The stereochemical configuration at C1?? of MC major ICL is R (? ICL). In contrast, Decarbamoylmitomycin C (DMC), a derivative of MC lacking the O10 carbamoyl group, generates the S stereoisomeric ICL (? ICL). The scientific premise of the proposed research is that ICLs constitute the molecular basis for the cytotoxic effects of mitomycins. The central hypothesis is that differences in the local DNA structures of the ? and ?-ICLs are responsible for the distinct biochemical responses triggered by MC and DMC. In particular, contrary to MC, the DNA-adducts generated by DMC treatment (?-ICL) rapidly activate a p53-independent cell death pathway. Thus, the study MC- DMC provides an ideal model for identifying structural features determining the cell signaling outcome in the presence or the absence of a functioning p53 pathway. The significance of this project lies in determining the structure-activity relationship for stereoisomeric DNA crosslink adducts. In addition, the proposed research will establish how the ? and ?-ICLs behave as biological signals to different cell death pathways. The key innovation of this project is to generate stereoisomeric ICLs on a scale which will allow the study of biochemical responses using our newly developed biomimetic method. Finally, since p53 tumor suppressor is frequently mutated in human cancers, the need to identify drugs and pathways that induce cell death or cell cycle arrest independently of p53 deserves substantial attention. In order to correlate MC and DMC-adducts structures with the toxicity of the ?-ICL and ?-ICL, the following three aims will be pursued: 1) Synthesis of MC and DMC DNA adducts. 2) Determination of p53-dependent and independent MC/DMC DNA adducts response mechanisms using proteomics. 3) Determination of the molecular signaling pathway involved the in G2/M cell cycle arrest triggered by MC/DMC DNA-adducts. Our study will reveal molecular and cellular networks up or downregulated by MC/DMC and the ?/?-ICLs in p53-dependent and p53-independent cell lines. The proposed work will therefore identify novel critical molecular therapeutic targets of MC and DMC.

Public Health Relevance

A lot of chemotherapeutic agents function through the activation of p53 and other apoptotic pathways, however at least 50 percent of all cancers do not have a functional p53-pathway. The proposed research will reveal molecular and cellular networks up or down regulated in the p53- independent mode of cell death triggered by DMC DNA adducts. Results may be used for personalized treatment consideration based on the genetic makeup of a tumor, particularly to tumors lacking the p53 transcriptional factor.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Continuance Award (SC3)
Project #
5SC3GM105460-06
Application #
9912784
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Krasnewich, Donna M
Project Start
2014-07-01
Project End
2023-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
John Jay College of Criminal Justice
Department
Other Basic Sciences
Type
Schools of Law or Criminology
DUNS #
620128863
City
New York
State
NY
Country
United States
Zip Code
10019
Cheng, Shu-Yuan; Vargas, Anayatzinc; Lee, Ji-Young et al. (2018) Involvement of Akt in mitomycin C and its analog triggered cytotoxicity in MCF-7 and K562 cancer cells. Chem Biol Drug Des 92:2022-2034
Aguilar, William; Paz, Manuel M; Vargas, Anayatzinc et al. (2018) Interdependent Sequence Selectivity and Diastereoselectivity in the Alkylation of DNA by Decarbamoylmitomycin?C. Chemistry 24:13278-13289
Zacarias, Owen; Aguilar, William; Paz, Manuel M et al. (2018) Isolation and Rationale for the Formation of Isomeric Decarbamoylmitomycin C- N6-deoxyadenosine Adducts in DNA. Chem Res Toxicol 31:762-771
Aguilar, William; Paz, Manuel M; Vargas, Anayatzinc et al. (2018) Sequence-Dependent Diastereospecific and Diastereodivergent Crosslinking of DNA by Decarbamoylmitomycin C. Chemistry 24:6030-6035
Napolitano, Tanya; Cheng, Shu-Yuan; Nielsen, Brooke et al. (2017) Acetone promoted 1,4-migration of an alkoxycarbonyl group on a syn-1,2-diamine. Tetrahedron Lett 58:597-601
Champeil, Elise; Cheng, Shu-Yuan; Huang, Bik Tzu et al. (2016) Synthesis of Mitomycin C and Decarbamoylmitomycin C N(2) deoxyguanosine-adducts. Bioorg Chem 65:90-9
Bose, Arindam; Surugihalli, Chaitra; Pande, Paritosh et al. (2016) Comparative Error-Free and Error-Prone Translesion Synthesis of N(2)-2'-Deoxyguanosine Adducts Formed by Mitomycin C and Its Metabolite, 2,7-Diaminomitosene, in Human Cells. Chem Res Toxicol 29:933-9
Cheng, Shu-Yuan; Seo, Jiwon; Huang, Bik Tzu et al. (2016) Mitomycin C and decarbamoyl mitomycin C induce p53-independent p21WAF1/CIP1 activation. Int J Oncol 49:1815-1824